Uncategorized

An AstraZeneca-Bristol Myers megamerger? Wall Street isn’t thrilled.

Published

on

In fact, the former lost tens of billions of dollars in market value following reports of a tie-up between the pharmaceutical giants.

Leave a Reply

Your email address will not be published. Required fields are marked *

Trending

Exit mobile version